openPR Logo
Press release

Human Papillomavirus 16-positive (HPV16+) Cancer Market to Witness Unstoppable Growth by 2027| Merck & Co., Inc., GlaxoSmithKline plc., Sanofi, Johnson & Johnson, AstraZeneca

09-01-2021 11:42 AM CET | Health & Medicine

Press release from: Report Consultant

Human Papillomavirus 16-positive (HPV16+) Cancer Market

Human Papillomavirus 16-positive (HPV16+) Cancer Market

Human papillomavirus (HPV) is the most common sexually transmitted infection, with a high probability of infection with the virus for both males and females across their lifetime.

Although the immune system eliminates most HPV infections without complications, some HPV-induced growths can progress to cancer. HPV 16 is the subtype found in most cancers and accounts for most cases of cervix, vagina, anus, and oropharynx cancers.

Despite advances in the understanding of the natural history of human papillomavirus infection and its role through persistence as the major risk factor in the development of cervical and other anogenital cancers, primary (vaccination) or secondary prevention programs (cervical screening) can impact decisively in preventing cancer, but both these approaches are not available for many at greatest risk.

Request a sample copy of this report @ Click here: –
https://www.reportconsultant.com/request_sample.php?id=90854

Key Players
Merck & Co., Inc., GlaxoSmithKline plc., Sanofi, Johnson & Johnson, AstraZeneca, Serum Institute of India Pvt. Ltd., and Bharat Biotech.

All those with HPV-driven chronic or neoplastic lesions and cancers potentially require therapy. If surgical removal is not possible or is unsuccessful, then other approaches are necessitated.

The disease epidemiology covered in the report provides historical as well as forecasted HPV 16+ Cancer epidemiology segmented as the Incident Cases of HPV-induced cancer.

Symptoms of early-stage cervical cancer may include:
• Irregular blood spotting or light bleeding between periods in women of reproductive age;
• Postmenopausal spotting or bleeding;
• Bleeding after sexual intercourse; and
• Increased vaginal discharge, sometimes foul smelling.

There are currently 3 vaccines that have been prequalified, all protecting against both HPV 16 and 18, which are known to cause at least 70% of cervical cancers.

The third vaccine protects against five additional oncogenic HPV types, which cause a further 20% of cervical cancers. Given that the vaccines which are only protecting against HPV 16 and 18 also have some cross-protection against these other less common HPV types which cause cervical cancer, WHO considers the three vaccines equally protective against cervical cancer.

Two of the vaccines also protect against HPV types 6 and 11, which cause anogenital warts.
Clinical trials and post-marketing surveillance have shown that HPV vaccines are very safe and very effective in preventing infections with HPV infections, high grade precancerous lesions and invasive cancer.

As cervical cancer advances, more severe symptoms may appear including:
• Persistent back, leg and/or pelvic pain;
• Weight loss, fatigue, loss of appetite;
• Foul-smell discharge and vaginal discomfort; and
• Swelling of a leg or both lower extremities.

Cervical cancer screening involves testing for pre-cancer and cancer, more and more testing for HPV infection is performed. Testing is done among women who have no symptoms and may feel perfectly healthy.

When screening detects an HPV infection or pre-cancerous lesions, these can easily be treated, and cancer can be avoided.
Screening can also detect cancer at an early stage and treatment has a high potential for cure.

There are 3 different types of screening tests that are currently recommended by WHO:
• HPV DNA testing for high-risk HPV types
• Visual inspection with Acetic Acid (VIA)
• conventional (Pap) test and liquid-based cytology (LBC)

Segmentation
By Type
• Bivalent
• Quadrivalent
• Nonavalent
By Indication
• Cervical Cancer
• Anal Cancer
• Oropharyngeal Cancer
• Genital Warts
• Others

Inquire Before Buying This Research Report: -
https://www.reportconsultant.com/enquiry_before_buying.php?id=90854

Key highlights of the global Human Papillomavirus 16-positive (HPV16+) Cancer Market:
- Full in-depth analysis of the parent market.
- Detailed information on factors that will accelerate the growth of the Human Papillomavirus 16-positive (HPV16+) Cancer Market during the next five years.
- Accurate predictions on upcoming trends and changes in consumer behavior.
- Former, on-going, and projected market analysis in terms of volume and value.
- The growth of the Human Papillomavirus 16-positive (HPV16+) Cancer industry across the Americas, APAC, and EMEA.
- Comprehensive details on factors that will challenge the growth of Human Papillomavirus 16-positive (HPV16+) Cancer companies.
Human Papillomavirus 16-positive (HPV16+) Cancer Market is being adopted mainly by manufacturing firms and chemical-based companies to reduce water wastage and for efficient use of their resources. Autocollimator’s technology helps organizations for identification of network problem, enhances customer engagement in water conservation and most prominently used to reduce non-revenue water losses due to damage of infrastructure.

Detailed TOC of Global Human Papillomavirus 16-positive (HPV16+) Cancer Market Research Report-
– Human Papillomavirus 16-positive (HPV16+) Cancer Market Introduction and Market Overview
– Human Papillomavirus 16-positive (HPV16+) Cancer Market, by Application
– Human Papillomavirus 16-positive (HPV16+) Cancer Market Industry Chain Analysis
– Human Papillomavirus 16-positive (HPV16+) Cancer Market, by Type
– Industry Manufacture, Consumption, Export, Import by Regions
– Industry Value ($) by Region
– Global Human Papillomavirus 16-positive (HPV16+) Cancer Market Status and SWOT Analysis by Regions
– Major Region of Human Papillomavirus 16-positive (HPV16+) Cancer Market
i) Global Human Papillomavirus 16-positive (HPV16+) Cancer Market Sales
ii) Global Human Papillomavirus 16-positive (HPV16+) Cancer Market Revenue & market share
– Major Companies List
– Conclusion

Rebecca Parker
(Report Consultant)
Contact No: +81-368444299
sales@reportconsultant.com
www.reportconsultant.com

About us:
Report Consultant is a prime destination for your business aptitude and analytical solutions because we provide qualitative and quantitative sources of information that are proficient to give one-stop solutions. We skillfully syndicate qualitative and quantitative research in exact proportions to have the best report, which not only gives the most recent insights but also assists you to grow.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Human Papillomavirus 16-positive (HPV16+) Cancer Market to Witness Unstoppable Growth by 2027| Merck & Co., Inc., GlaxoSmithKline plc., Sanofi, Johnson & Johnson, AstraZeneca here

News-ID: 2376447 • Views:

More Releases from Report Consultant

Biopsy Needle Market- Increasing Demand with Industry Professionals: Ethicon Endo Surgery, Intact Medical Corporation, Galini SRL, Hologic Inc.
Biopsy Needle Market- Increasing Demand with Industry Professionals: Ethicon End …
A new market study report by Report Consultant on the Biopsy Needle Market has been released with reliable information and accurate forecasts for a better understanding of the current and future market scenarios. The report offers an in-depth analysis of the global market, including qualitative and quantitative insights, historical data, and estimated projections about the market size and share in the forecast period. The forecasts mentioned in the report have
Serverless Architecture Market Giants Spending Is Going to Boom With Alibaba Group, Amazon Web Services, Google LLC, IBM Corporation, Microsoft Corporation
Serverless Architecture Market Giants Spending Is Going to Boom With Alibaba Gro …
Global Serverless Architecture Market is a latest research study released by Report Consultant evaluating the market risk side analysis, highlighting opportunities and leveraged with strategic and tactical decision-making support. The report provides crucial statistics on the market status of the leading Serverless Architecture market players and offers information on market trends and development, growth drivers, technologies, and the changing investment structure of the Global Serverless Architecture Market. The report uses
Remittance Market Growth, Developments Analysis and Precise Outlook 2023 to 2030 Bank of America, Citigroup Inc., JPMorgan Chase & Co.
Remittance Market Growth, Developments Analysis and Precise Outlook 2023 to 2030 …
Global Remittance Market Research Report initially provides a basic overview of the industry that covers definition, applications and technology, post which the report explores into the international players in the market. The report profiles the key players in the industry, along with a detailed analysis of their individual positions against the global landscape. The study conducts SWOT analysis to evaluate strengths and weaknesses of the key players in the market.
Consumer IoT Market 2023 is Booming Globally with Top Key Players- Cisco Systems, Inc., Honeywell International Inc., Infineon Technologies, Intel Corporation
Consumer IoT Market 2023 is Booming Globally with Top Key Players- Cisco Systems …
Global Consumer IoT Market Report is a compilation of comprehensive research studies on various aspects of the Consumer IoT Market. With accurate data and highly authentic information, it makes a brilliant attempt to provide a real, transparent picture of current and future situations of the global Consumer IoT Market. Market participants can use this powerful tool when creating effective business plans or making important changes to their strategies. The report

All 5 Releases


More Releases for HPV

Human Papillomavirus (HPV) Vaccines Market is Thriving Worldwide with Top Compan …
Los Angeles, United State, –The report titled Global Human Papillomavirus (HPV) Vaccines Market is one of the most comprehensive and important additions to QY Research’s archive of market research studies. It offers detailed research and analysis of key aspects of the global Human Papillomavirus (HPV) Vaccines market. The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities to offer a complete
HPV Vaccines Market 2020-2026 - COVID19 Impact On HPV Vaccines Industry | Top Ke …
HPV Vaccines Market Size, Share & Industry Analysis, By Type (Bivalent and Polyvalent), By Disease Indication (HPV Associated Cancer and Genital Warts), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, and Others) and Geography Forecast, 2019-2026. Get Sample Copy Of Report To Know The Impact of Covid19 on this Industry: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/human-papillomavirus-hpv-vaccines-market-101962 Top Key Players: GSK, Merck. An Overview of the Impact of COVID-19 on HPV Vaccines Market: The emergence of COVID-19 has brought
HPV Testing & PAP Test Market by Test Type (HPV Testing, Follow-up HPV Testing, …
Global HPV Testing & PAP Test Market was valued at USD XX billion in the year 2017. Global HPV Testing & PAP Test market is further estimated to grow at a CAGR of XX % from 2018 to reach USD XX billion by the year 2023. Get Free Access to Sample Report @ https://genesismarketinsights.com/Sample_Request/GENRE385 In the Global HPV Testing & PAP Test Market, by region, North America holds the highest market share
Human Papillomavirus (HPV) Therapeutics Market to Reach US$2.34 bn by 2020, Driv …
Human papillomavirus (HPV) and cytomegalovirus (CMV) are viral pathogens affecting individuals of all ages. HPV causes serious sexually transmitted diseases (STDs), while CMV is an opportunistic pathogen affecting immunocompromised individuals such as HIV patients. The global market for HPV and CMV therapeutics is expected to experience a surge due to various macro and micro economic factors. Read the Comprehensive Overview of Human Papillomavirus (HPV) Therapeutics Market:
Cytology and HPV Testing Market: Disparate Levels of Awareness among Patients Re …
Over the years, the level of awareness among the global population regarding the various types of cancer has increased tremendously. The significance of early detection and diagnosis is not lost on them, resulting in the increased adoption of screening tests such as cytology and human papillomavirus (HPV) testing. The global market for cytology and HPV testing is presented with a host of sustained growth opportunities arising mainly from several emerging economies,
New Research: Global Human Papillomavirus (HPV) Market
MarketResearchReports.Biz presents this most up-to-date research on "Human Papillomavirus (HPV)- Epidemiology Forecast To 2023" Latest Report, Human Papillomavirus (HPV) - Epidemiology Forecast To 2023 provides an overview of the epidemiology trends of Human Papillomavirus (HPV) in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Human Papillomavirus (HPV) prevalent or incident cases segmented by age, sex and subpopulations. The